Dr. Anish Ray, Cook Children’s Medical Center, United States
Dr. Anish K. Ray is a renowned Pediatric Hematologist/Oncologist at Cook Children’s Medical Center, Texas, USA. With over 20 years of experience, Dr. Ray specializes in precision medicine, histiocytic disorders, and targeted therapeutics. He serves as Director of the Histiocytic Disorders Program and Vice President of the Human Research Protection Program. Dr. Ray has received several awards, published numerous papers, and presented at international conferences. His research focuses on improving treatment outcomes for pediatric cancer and blood disorders, enhancing patient care through precision medicine.
Profile
Orcid
Educational Qualification📚
Dr. Anish K. Ray pursued his graduate medical education at Calcutta National Medical College, Kolkata, India, from 1996 to 2002. He then completed his post-graduate training and fellowship appointments at renowned institutions in the United States.
Professional Endeavors💼
Dr. Ray currently serves as an Attending Physician in Pediatric Hematology/Oncology at Cook Children’s Hospital, Fort Worth, Texas, since 2012. He also holds various leadership positions, including Director of the Histiocytic Disorders Program and Vice President, Medical Director of the Human Research Protection Program.
Contributions and Research Focus🔬
Dr. Ray’s research focuses on pediatric hematology/oncology, with an emphasis on precision medicine, histiocytic disorders, and targeted therapeutics. He has published numerous papers in reputable journals and presented at international conferences.
Accolades and Recognition🏆
Dr. Ray has received several awards, including:
Recipient, Hyundai Young Investigator Award for $150,000
Recipient, Pediatric Teacher of the Year Award, University of North Texas College of Osteopathic Medicine
Recipient, Certificate of Recognition, Distinguished Consultant, Cook Children’s Physician Network
Impact and Influence💡
Dr. Ray’s work has significantly impacted the field of pediatric hematology/oncology, particularly in the areas of precision medicine and histiocytic disorders. His research has improved treatment outcomes and quality of life for patients.
Legacy and Future Contributions🔜
Dr. Ray continues to contribute to the medical community through his research, teaching, and leadership. His future endeavors will likely focus on advancing precision medicine and improving patient care.
Professional Memberships 📝👥
American Society of Hematology
American Society of Pediatric Hematology and Oncology Children’s Oncology Group
Publication Top Notes📖🖋️
Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders
Contributors: Cournoyer, E.; Ferrell, J.; Sharp, S.; Ray, A.; Jordan, M.; Dandoy, C.; Grimley, M.; Roy, S.; Lorsbach, R.; Merrow, A.C. et al.
Contributors: Sandra Kumar; Angelica Gonzalez; David Farbo; Karen Albritton; Anish Ray
Journal: Radiation
Year: 2024
Contributors: Natalia Wojciechowska; Kaci Orr; Karen Albritton; Kenneth Heym; Kelly Vallance; Lauren Murray; Rocio Aguilar; Anish Ray
Journal: Hemato
Year: 2024